Safety issues with transdermal opioid medications - Australian and ...

More documents

Recommendations

Info

IIMS NOTIFICATIONS – A SIGNAL • Notification to the NSW incident database is voluntary. Culture and enthusiasm varies amongst and within the Areas. • Quality of data entry varies with notifier, but qualitative data can be very useful. • The notifications are useful for emerging trends – a signal but not reliable for quantitative reporting.
New South Wales IIMS data 1. - Medications Transdermal medications reported to NSW IIMS July 06 to June 07 ( 330) Frequency 350 300 250 200 150 100 50 0 Medication GTN Fentanyl Buprenorphine Nicotine Fent/bup Unknown Hyoscine Emla HRT Frequency 128 108 49 28 9 4 3 1 1 Percent 38.7 32.6 14.8 8.5 2.7 1.2 0.9 0.3 0.3 Cum % 38.7 71.3 86.1 94.6 97.3 98.5 99.4 99.7 100.0 100 80 60 40 20 0 Percent
Page 1 and 2: Safety issues with transdermal opio
Page 3 and 4: An example • Patient arrived in E
Page 5: Cross section of a Norspan transder
Page 9 and 10: Well, this doesn’t t appear to be
Page 11 and 12: And again - a common notification
Page 13 and 14: Perceived problems with patches Per
Page 15 and 16: And the culprits are? 100 95 Notifi
Page 17 and 18: 100 80 Percent 60 Buprenorphine Bup
Page 19 and 20: Did the Alert make a difference?
Page 21 and 22: Warnings at Home
Page 23 and 24: MIMS Prescribing information also c
Page 25 and 26: What can you do as pain specialists
Page 27 and 28: All about communication - 2

Safety issues with transdermal opioid medications - Australian and ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?